Erratum: Rosiglitazone preserves pulmonary vascular function in lambs with increased pulmonary blood flow

Peter E. Oishi, Shruti Sharma, Sanjeev A. Datar, Sanjiv Kumar, Saurabh Aggarwal, Qing Lu, Gary Raff, Anthony Azakie, Jong-Hau Hsu, Eniko Sajti, Sohrab Fratz, Stephen M. Black and Jeffrey R. Fineman

Pediatr Res 73:54–61 (2013); doi:10.1038/pr.2012.149

After the article was published, the authors realized that the representative western blot in Figure 6 could be misconstrued as showing that the far right lane was contiguous. In fact, the far right lane is a noncontiguous lane from the same gel. The cumulative data represented in the bar graph are correct.

A revised figure and legend are shown below.

Figure 1

Lung tissue protein expression of peroxisome proliferator–activated receptor (PPAR-γ) in normal (white bar) and vehicle- (black bar) and rosiglitazone (RG)-treated (gray bar) shunt lambs. PPAR-γ was decreased in vehicle-treated shunt lambs as compared with normal lambs and increased in RG-treated shunt lambs as compared with vehicle-treated shunt lambs. Representative western blots are shown. The far right lane is a noncontiguous lane from the same gel. Densitometric values for PPAR-γ protein are shown relative to normal. n = 5 for normal group; n = 5 for vehicle-treated shunt group; n = 6 for RG-treated shunt group. Values are mean ± SD. *P < 0.05 as compared with normal group. †P < 0.05 as compared with vehicle-treated shunt group.

PowerPoint slide